Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Pharmaceutics|June 19, 2001
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptidesL Illum, A N Fisher, I Jabbal-Gill, et al.
Advanced Drug Delivery Reviews|August 23, 2001
Polymeric lamellar substrate particles for intranasal vaccinationI Jabbal-Gill, W Lin, O Kistner, et al.
Vaccine|October 31, 1998
Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in miceI Jabbal-Gill, A N Fisher, R Rappuoli, et al.
Advanced Drug Delivery Reviews|August 23, 2001
Chitosan as a novel nasal delivery system for vaccinesL Illum, I Jabbal-Gill, M Hinchcliffe, et al.
Vaccine|March 5, 2003
Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c miceM Iqbal, W Lin, I Jabbal-Gill, et al.
Pharmaceutical Research|August 16, 2002
Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticlesA M Dyer, M Hinchcliffe, P Watts, et al.
Infection and Immunity|September 19, 2000
Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigensA Bacon, J Makin, P J Sizer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Intranasal delivery of morphineL Illum, P Watts, A N Fisher, et al.
Vaccine|January 4, 2001
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryE A McNeela, D O'Connor, I Jabbal-Gill, et al.
Pageof 1